Five-year survival rate

What it is

A five-year survival rate is the percentage of people with a particular tumor who are still living five years after diagnosis. For gliomas, this rate varies widely by type — from high for often-curable tumors to low for the most aggressive — and, like all survival statistics, it describes populations rather than predicting any individual's outcome.

Understanding Five-year survival rate

Five-year survival rates are a common way to summarize long-term outcomes and to compare different tumor types. The variation across gliomas is striking: pilocytic astrocytoma has a very high five-year survival rate (these tumors are often cured), whereas glioblastoma has a low five-year survival rate (reflecting its aggressiveness). These rates are population statistics based on groups of people diagnosed in the past, so they may not fully reflect the most recent treatment advances, and they cannot predict how any individual will do — many factors influence an individual's course, and some people do better than the statistics suggest. Five-year survival rates can inform general understanding of a tumor type, but they should be interpreted cautiously and in personal context with the care team. They are one of several ways outcomes are described. Understanding five-year survival rates in gliomas clarifies a widely varying population statistic.

Why it matters

Understanding five-year survival rates helps patients and families interpret this statistic — varying widely by glioma type — as a population figure based on past data, not an individual prediction, best understood in personal context.